文献速递产科母胎医学

七个中低收入国家COVID-19抗体阳性率随时间变化与妊娠结局:全球妇女儿童健康研究网络的前瞻性观察研究

COVID-19 antibody positivity over time and pregnancy outcomes in seven low-and-middle-income countries: A prospective, observational study of the Global Network for Women's and Children's Health Research.
PubMed 文献 · BJOG · 2023-01-02

在七个中低收入国家的前瞻性观察队列中,分娩时COVID-19抗体阳性率为26.0%,四个时段依次为13.8%、15.4%、21.0%和40.9%。校正部位和母亲特征后,死产、新生儿死亡、低出生体重和早产与抗体阳性无显著关联,产后出血与抗体阳性相关(aRR 1.44;95%CI 1.01-2.07)。

要点

  • 分娩时COVID-19抗体阳性率26.0%,四个时段依次为13.8%、15.4%、21.0%、40.9%。
  • 校正后死产、新生儿死亡、低出生体重、早产与抗体阳性无显著关联。
  • 产后出血与抗体阳性相关,aRR 1.44(95%CI 1.01-2.07)。

核心结论

  • 在中低收入国家孕妇人群中,COVID-19抗体阳性率上升,但多数不良妊娠结局与抗体阳性无显著关联。
  • 校正部位和母亲特征后,产后出血与抗体阳性相关(aRR 1.44;95%CI 1.01-2.07)。

研究设计与样本

  • 前瞻性观察队列研究,在七个中低收入国家(肯尼亚、赞比亚、刚果民主共和国、孟加拉国、巴基斯坦、印度两个站点和危地马拉)进行。
  • 研究对象为全球妇女儿童健康研究网络母婴健康登记处(MNHR)中正在进行的妊娠登记所纳入的孕妇。
  • 2020年10月至2021年10月,对入组妇女在分娩时进行标准化COVID-19抗体检测,由不知晓COVID-19状态的培训人员获取妊娠结局。

主要发现

  • 分娩时26.0%的妇女COVID-19抗体阳性。
  • 四个时段抗体阳性率依次为13.8%、15.4%、21.0%和40.9%。
  • 最后一时段各站点阳性率:刚果民主共和国27.0%、肯尼亚33.1%、巴基斯坦32.8%、危地马拉37.0%、赞比亚37.8%、孟加拉国47.2%、印度那格浦尔57.4%、印度贝拉加维62.4%。
  • 校正部位和母亲特征后,死产、新生儿死亡、低出生体重和早产与COVID-19无显著关联,死产aRR 1.27(95%CI 0.95-1.69)。
  • 产后出血与抗体阳性相关(aRR 1.44;95%CI 1.01-2.07)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine COVID-19 antibody positivity rates over time and relationships to pregnancy outcomes in low- and middle-income countries (LMICs). DESIGN: With COVID-19 antibody positivity at delivery as the exposure, we performed a prospective, observational cohort study in seven LMICs during the early COVID-19 pandemic. SETTING: The study was conducted among women in the Global Network for Women's and Children's Health's Maternal and Newborn Health Registry (MNHR), a prospective, population-based study in Kenya, Zambia, the Democratic Republic of the Congo (DRC), Bangladesh, Pakistan, India (two sites), and Guatemala. POPULATION: Pregnant women enrolled in an ongoing pregnancy registry at study sites. METHODS: From October 2020 to October 2021, standardised COVID-19 antibody testing was performed at delivery among women enrolled in MNHR. Trained staff masked to COVID-19 status obtained pregnancy outcomes, which were then compared with COVID-19 antibody results. MAIN OUTCOME MEASURES: Antibody status, stillbirth, neonatal mortality, maternal mortality and morbidity. RESULTS: At delivery, 26.0% of women were COVID-19 antibody positive. Positivity increased over the four time periods across all sites: 13.8%, 15.4%, 21.0% and 40.9%. In the final period, positivity rates were: DRC 27.0%, Kenya 33.1%, Pakistan 32.8%, Guatemala 37.0%, Zambia 37.8%, Bangladesh 47.2%, Nagpur, India 57.4% and Belagavi, India 62.4%. Adjusting for site and maternal characteristics, stillbirth, neonatal mortality, low birthweight and preterm birth were not significantly associated with COVID-19. The adjusted relative risk (aRR) for stillbirth was 1.27 (95% CI 0.95-1.69). Postpartum haemorrhage was associated with antibody positivity (aRR 1.44; 95% CI 1.01-2.07). CONCLUSIONS: In pregnant populations in LMICs, COVID-19 antibody positivity has increased. However, most adverse pregnancy outcomes were not significantly associated with antibody positivity.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Goldenberg RL, Saleem S, Billah SM, et al. COVID-19 antibody positivity over time and pregnancy outcomes in seven low-and-middle-income countries: A prospective, observational study of the Global Network for Women's and Children's Health Research. BJOG. 2023. PMID: 36504437. doi:10.1111/1471-0528.17366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。